- $99.43bn
- $118.21bn
- £31.38bn
- 92
- 66
- 99
- 98
REG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - GSK Consumer Healthcare to be called Haleon
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - GSK gives update on RSV maternal vaccine candidate
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - GlaxoSmithKline PLC - Transfer of Treasury Shares
AnnouncementREG - GlaxoSmithKline PLC - Benlysta approved in China for Lupus Nephritis
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Final Results
AnnouncementREG - GlaxoSmithKline PLC - Publication of full year 2021 results
AnnouncementREG - Allianz Glbl Inv - Top 10 Holdings
Announcement